Xconomy

SEPTEMBER 27, 2016

San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

DECEMBER 6, 2012

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures. READ MORE>>.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

AUGUST 30, 2010

The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures. The firm said the new fundings will go to support its programs through clinical studies. Tags: otonomy biopharma biopharmaceuticals inner middle biotech lifescience venture capital.

Avalon 150

Avalon San Diego Venture Capital Study 150

socalTECH

JUNE 11, 2010

The round came from Avalon Ventures. According to Otonomy, the funding will go towards supporting the ongoing clinical trial for its compound, to initiate IND studies for a second compound, and early-stage development of a third program. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures.

Avalon 113

Avalon San Diego Study Capital 113

Xconomy

AUGUST 17, 2016

and San Diego’s Avalon Ventures. Inbio Ventures, a venture capital management company, represented Pharmstandard in the deal. Avalon Ventures founded Avelas, and has housed the startup with other Avalon biotech startups at its COI Pharmaceuticals R&D facility in San Diego. Carmine Stengone.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

JULY 20, 2016

Then came COI Pharmaceuticals , the shared “community of innovation” for startup biotechs established by San Diego’s Avalon Ventures as part of its partnership with GlaxoSmithKline. It’s a little like what Avalon is doing. We are taking capital as needed, not sooner.”. But it’s structured differently.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40